mdlinx mdlinx

Oncology - Side Effects News & Articles

Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.

On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx
New! >> Find out who is the Smartest Doc in Oncology!

Articles

Latest Full Text Articles (84) Focus on Bone
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

501 Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study British Journal of Cancer, January 31, 2011

502 Dapsone-induced methemoglobinemia Cancer, January 31, 2011

503 Xerostomia after radiotherapy in the head&neck area: Long-term observations Radiotherapy & Oncology, January 28, 2011

504 Evaluation of Acute Locoregional Toxicity in Patients With Breast Cancer Treated With Adjuvant Radiotherapy in Combination With Bevacizumab International Journal of Radiation Oncology*Biology*Physics, January 28, 2011    Clinical Article

505 The Impact of Pretreatment Prostate Volume on Severe Acute Genitourinary Toxicity in Prostate Cancer Patients Treated With Intensity-Modulated Radiation Therapy International Journal of Radiation Oncology*Biology*Physics, January 28, 2011

506 Nephrotic syndrome developing during induction chemotherapy for childhood acute lymphoblastic leukemia Clinical and Experimental Nephrology, January 28, 2011

507 Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC) Radiotherapy & Oncology, January 27, 2011    Clinical Article

508 Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting Supportive Care in Cancer, January 25, 2011    Clinical Article

509 The role of S-adenosylmethionine in preventing oxaliplatin-induced liver toxicity: a retrospective analysis in metastatic colorectal cancer patients treated with bevacizumab plus oxaliplatin-based regimen Supportive Care in Cancer, January 25, 2011

510 Efficacy and toxicity of concurrent chemoradiotherapy in patients with advanced oropharyngeal squamous cell carcinoma Cancer Chemotherapy and Pharmacology, January 24, 2011    Clinical Article

511 Decreasing the Adverse Effects of Cancer Therapy: National Cancer Institute Guidance for the Clinical Development of Radiation Injury Mitigators Full Text Clinical Cancer Research, January 21, 2011

512 Retrospective multicenter study on the development of peripheral lymphocytosis following second-line dasatinib therapy for chronic myeloid leukemia American Journal of Hematology, January 21, 2011

513 Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment Full Text BMC Cancer, January 14, 2011

514 Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review Angiogenesis, January 14, 2011

515 Black Hairy Tongue After Allogeneic Stem Cell Transplantation: An Unrecognized Cutaneous Presentation of Graft-Versus-Host Disease Transplantation Proceedings, January 12, 2011

516 Correlation of Currently Used Radiobiological Parameters with Local Control and Acute and Late Mucosal Toxicity in Randomised Studies of Altered Fractionation for Locally Advanced Head and Neck Cancer Clinical Oncology, January 12, 2011

517 Evaluation of estrogen and progesterone receptors in non-neoplastic breast tissue of women of reproductive age exposed to tamoxifen and raloxifene: a randomized, double-blind study Breast Cancer Research and Treatment, January 11, 2011    Clinical Article

518 Haemolytic anaemia and renal failure associated with antibodies to trimethoprim and sulfamethoxazole Transfusion Medicine, January 7, 2011

519 A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findings British Journal of Cancer, January 6, 2011

520 Evaluation of empiric versus nomogram based direct thrombin inhibitor management in patients with suspected heparin induced thrombocytopenia American Journal of Hematology, January 4, 2011

50 available pages First Previous 26 27 28 29 30 31 32 33 34 35 Next Last

Clinical Pearls in Oncology

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.

Read the article summary

HCC risk increased in patients with AIDS

As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.

Read the article summary

RAB25 is a prognostic marker for ovarian cancer

As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Oncology Articles

Last month's top read Top Articles of 2012

1 Toxicity of Bevacizumab in Combination with Chemotherapy in Older Patients The Oncologist, April 15, 2013    Free full text

2 Malignant Pericardial Effusion Cardiology, April 8, 2013

3 Enalapril And Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients with Malignant Hemopathies. The OVERCOME Trial JACC - Journal of the American College of Cardiology, April 12, 2013

4 Cardiac Magnetic Resonance Imaging in the Evaluation of the Late Effects of Anthracyclines Among Long-Term Survivors of Childhood Cancer JACC - Journal of the American College of Cardiology, April 5, 2013

5 Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy Journal of the National Cancer Institute, April 18, 2013

6 Bevacizumab and central nervous system (CNS) hemorrhage Cancer Chemotherapy and Pharmacology, April 9, 2013

7 Biomolecular markers of cancer-associated thromboembolism Critical Reviews in Oncology/Hematology, April 2, 2013

8 Risk of postoperative venous thromboembolism after minimally invasive surgery for endometrial and cervical cancer is low: A multi institutional study Gynecologic Oncology, April 24, 2013

9 Brain and Neck Tumors Among Physicians Performing Interventional Procedures The American Journal of Cardiology, April 29, 2013

10 Cetuximab/cisplatin and radiotherapy in HNSCC: is there a favorite choice? Central European Journal of Medicine, April 23, 2013

11 A predictive model for dysphagia following IMRT for head and neck cancer: Introduction of the EMLasso technique Radiotherapy & Oncology, April 26, 2013

12 The Correlation Between Dose of Folinic Acid and Neurotoxicity in Children and Adolescents Treated for Osteosarcoma With High-dose Methotrexate (HDMTX): A Neuropsychological and Psychosocial Study Journal of Pediatric Hematology/Oncology, April 29, 2013

13 Update on antiangiogenic therapy in colorectal cancer: aflibercept and regorafenib Journal of Gastrointestinal Oncology, April 25, 2013    Free full text

14 Toxicities, complications, and clinical encounters during intraperitoneal chemotherapy in 17 women with ovarian cancer European Journal of Oncology Nursing , April 23, 2013

15 Venous thromboembolism in adults treated for acute lymphoblastic leukaemia: Effect of fresh frozen plasma supplementation Thrombosis and Haemostasis, April 23, 2013

16 Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index Journal of Clinical Oncology, April 1, 2013

17 Single-dose Palonosetron and Dose-reduced Regimen of Dexamethasone in Preventing Nausea and Vomiting by Anthracycline-including Chemotherapy in Patients with Early Breast Cancer Anticancer Research, April 10, 2013

18 Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV Supportive Care in Cancer, April 3, 2013

19 The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer BMC Cancer, April 5, 2013    Free full text

20 Population PK/PD modeling of eltrombopag in subjects with advanced solid tumors with chemotherapy-induced thrombocytopenia Cancer Chemotherapy and Pharmacology, April 10, 2013

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Other Topics in Oncology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close